Thimerosal, MMR Vaccines Not Associated With Autism, IoM Report Concludes
This article was originally published in The Pink Sheet Daily
Executive Summary
Report updates 2001 reports that were “unclear” about link between thimerosal and neurodevelopment disorders.
You may also be interested in...
Sanofi-Aventis Removes Thimerosal From Adult Tetanus/Diphtheria Vaccine
Decavac will be priced at a 78% premium to the discontinued thimerosal-containing version of the vaccine due to additional manufacturing and packaging costs. The company is working with FDA to reduce or remove thimerosal from all its vaccine products.
Sanofi-Aventis Removes Thimerosal From Adult Tetanus/Diphtheria Vaccine
Decavac will be priced at a 78% premium to the discontinued thimerosal-containing version of the vaccine due to additional manufacturing and packaging costs. The company is working with FDA to reduce or remove thimerosal from all its vaccine products.
Vaccine Safety Body Proposed To Remove FDA "Conflict Of Interest"
A proposal to move post-market vaccine safety surveillance to an independent board will be discussed by the National Vaccine Advisory Committee at its next meeting. FDA and CDC are defending the current system as enabling communication between risk management and risk assessment staff.